ArticleCureus2025
Types of Vascular Access and Associated Clinical Outcomes in Dialysis Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Platelet-Based Markers Associated With Vascular Access Dysfunction in Hemodialysis Patients.Cureus · 2026Article
- Use of machine learning models to predict mortality in dialysis patients.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Vascular access in patients with end-stage renal disease (ESRD) plays a crucial role in determining both the quality of life and survival rates, as it directly affects dialysis effectiveness. It connects the patient to the dialysis machine and significantly impacts the dialysis dose by influencing blood flow efficiency. Despite advancements in technology, improved care, and collaborative efforts by healthcare providers and patients, complications related to vascular access continue to be a major cause of hospitalizations and mortality among patients with ESRD. Our study aims to evaluate how vascular access impacts the dialysis dose and clinical outcomes, with the ultimate target of enhancing patients' quality of life while minimizing costs to the healthcare system. We seek to identify new strategies to reduce complications associated with vascular access, which contribute to inadequate dialysis and higher mortality rates, and to encourage the integration of these strategies into routine clinical practice. Methodology This retrospective study was conducted at the Clinic of Nephrology and Dialysis at the University Hospital "St. Marina" in Varna, Bulgaria, over five years, from January 2017 to December 2021. During this period, the medical records and routine laboratory tests of 87 patients who met the study criteria were reviewed. Patients were categorized into two groups based on the type of permanent vascular access: Group 1 included 45 patients with an arteriovenous fistula (AVF), and Group 2 included 42 patients with a permanent tunneled vascular catheter (PC). During the study period, the specified indicators, along with recorded mortality and hospitalization rates, were analyzed in relation to the type of vascular access. Results Our analysis demonstrated the significant superiority of AVF in several key areas. Specifically, patients with AVF showed significantly higher dialysis adequacy, as measured by the single-pool Kt/V index (spKt/V) and urea reduction ratio (URR), along with higher serum hemoglobin levels and lower erythropoietin requirements (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.